Results 101 to 110 of about 175,494 (162)

Exploring global research trends in sublingual immunotherapy of allergic rhinitis: a comprehensive bibliometric analysis. [PDF]

Immunotherapy
Gu W, Shen Z, Shi J, Xu H, Dong H, Yan D, Chu Y.   +6 more
europepmc   +1 more source

Tolerance-guided dose adjustment in sublingual immunotherapy for children with dust mite-induced allergic rhinitis: a 6-month prospective cohort study. [PDF]

Front Med (Lausanne)
Wang M, Li Z, Song J, Zhou Y, Dai X, Deng Y, Ma J, Gao Y.   +7 more
europepmc   +1 more source

Improvement in nasal signs and eosinophils following 3 years of sublingual immunotherapy for allergic rhinitis. [PDF]

Front Immunol
Liu B, Hu S, Xiao M.
europepmc   +1 more source

Early and longitudinal response to sublingual immunotherapy across pediatric allergic multimorbidity patterns: A 3-year real-world cohort study. [PDF]

Pediatr Allergy Immunol
Gonzalez-Uribe V, Prieto-Gomez J, Moreno-Castro S, Martinez-Tenopala R, Rendon-Salazar MJ, Hernandez-Hernandez T, Mojica-Gonzalez ZS, de Baro-Alvarez P.   +7 more
europepmc   +1 more source

Evaluation of sIgE Qualitative Conversion and Clinical Response to HDMs Sublingual Immunotherapy: Insights from Three Immunoassays. [PDF]

Biomolecules
Gheith T, Rohayem SM, El Bahrawy AT, Mesbah AE, Salem SGA, Hammad NM.   +5 more
europepmc   +1 more source

A Pediatric Case of Reversible Eosinophilic Duodenitis Associated With Sublingual Immunotherapy. [PDF]

Pediatr Int
Yabe K, Shida M, Inagi Y, Shibusawa H, Sato M, Hosoi K.   +5 more
europepmc   +1 more source

Modulation of type 2 inflammation during grass pollen-specific sublingual immunotherapy. [PDF]

Front Immunol
Salvati L, Capone M, Mazzoni A, Vanni A, Lamacchia G, Scaletti C, Parronchi P, Liotta F, Annunziato F, Cosmi L, Maggi L.   +10 more
europepmc   +1 more source

Efficacy and safety of <i>Artemisia annua</i> pollen sublingual immunotherapy in patients with seasonal allergic rhinoconjunctivitis with or without comorbid asthma: A real-world study. [PDF]

J Int Med Res
Hao W, Liu X, Gao N, Bai C.
europepmc   +1 more source

Three-year sublingual immunotherapy for HDM-induced allergic rhinoconjunctivitis: sustained ocular symptom improvement. [PDF]

Front Med (Lausanne)
Liu C, Jiang H, Long Y, Jiang F, Chen L.
europepmc   +1 more source

Efficacy and safety of the tree sublingual immunotherapy tablet in the subpopulation of Canadian children with allergic rhinitis and/or conjunctivitis: phase III trial results. [PDF]

Allergy Asthma Clin Immunol
Gagnon R, Dalgaard T, Ortving GS, Gappa M, Nolte H.   +4 more
europepmc   +1 more source